Mechanistically, this synergistic effect is based on lapatinib-induced inhibition of the MDR efflux transporter ABCB1, which is frequently expressed in drug-resistant NB cells, thereby prolonging and enhancing the cytotoxicity of YM155 (Radic-Sarikas et al., 2017). This evidence concerns the gene ABCB1 and neuroblastoma.